Office-based solutions Leverage Urgent PC Neuromodulation System as a non-drug, non-surgical office-based treatment for overactive bladder to target providers seeking minimally invasive options that can expand patient reach and reduce surgery referrals.

Fecal incontinence potential Explore expansion opportunities outside the US for Macroplastique related to fecal incontinence, identifying international markets with regulatory pathways where injectable urethral bulking could complement existing female stress urinary incontinence offerings.

Cross-sell to specialists Position Uroplasty products as complementary options for specialty physicians managing voiding dysfunction, enabling multi-modality treatment portfolios within urology clinics and pelvic health centers.

SMB-focused sales Target clinics and smaller practice groups that would benefit from in-office treatments to improve patient throughput, satisfaction, and practice efficiency given the company’s small-to-mid enterprise footprint.

Strategic partnerships Leverage the scaling gap relative to larger competitors by forming partnerships with distributors and ambulatory surgery networks to accelerate adoption, training, and on-site demonstrations of Urgent PC and Macroplastique offerings.